Cervical Cancer Screening Rates Dropped During Stay-at-Home Order
THURSDAY, Jan. 28, 2021 -- There was a considerable decrease in the cervical cancer screening rate during the stay-at-home order issued by the governor of California on March 19, 2020, to contain the spread of severe acute respiratory syndrome coronavirus 2, according to research published in the Jan. 29 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Maureen J. Miller, M.D., from the CDC in Atlanta, and colleagues examined electronic medical records for about 1.5 million women served by Kaiser Permanente Southern California health care system to assess cervical cancer screening rates before, during, and after the stay-at-home order issued by the governor of California on March 19, 2020.
The researchers observed a substantial decrease in cervical cancer screening rates during the stay-at-home order compared with the 2019 baseline. Cervical cytology screening rates per 100 person-months decreased 78 percent among women aged 21 to 29 years. For women aged 30 to 65 years, there was an 82 percent decrease in human papillomavirus test screening rates per 100 person-months. Screening rates returned to near baseline after the stay-at-home order was lifted, which could have been aided by the organized screening program that included reminder systems and tracking persons lost to follow-up.
"As the pandemic continues, public health interventions to address decreases in cancer screening rates will be critical to avoid increased incidence of advanced cancers because of delayed detection," the authors write.
© 2021 HealthDay. All rights reserved.
Posted: January 2021
Read this next
THURSDAY, Feb. 11, 2021 -- Human papillomavirus (HPV) infection in the oral cavity has been detected in infants and young children, according to a study published in the March...
TUESDAY, Feb. 9, 2021 -- From 2012 to 2018, there was an increase in the proportion of unvaccinated adolescents who received a recommendation for human papillomavirus (HPV)...
MONDAY, Jan. 11, 2021 -- In addition to number of oral sex partners, timing and intensity of oral sex are independent risk factors for human papillomavirus-related oropharyngeal...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.